Study on the mechanism of intestinal absorption of Epimedins A, B and C in the Caco-2 cell model

Molecules

Volumn 19, Issue 1, 2014, Pages 686-698

  Chen, Yan ^a   Wang, Ying ^a,b   Zhou, Jing ^a   Gao, Xia ^a   Qu, Ding ^a   Liu, Congyan ^a  

^a KEY LABORATORY OF NEW DRUG DELIVERY SYSTEM OF CHINESE MATERIA MEDICA   (China)

^b JIANGSU UNIVERSITY   (China)

Author keywords

Absorption; Caco 2 cell monolayer model; Dipyridamole; Epimedin A; Epimedin B; Epimedin C; Inhibitors; MK571; Verapamil

Indexed keywords

DIPYRIDAMOLE; EPIMEDIN A; EPIMEDIN B; EPIMEDIN C; FLAVONOID; MULTIDRUG RESISTANCE PROTEIN; PROPIONIC ACID DERIVATIVE; QUINOLINE DERIVATIVE; VERAPAMIL; VERLUKAST;

ARTICLE; CACO 2 CELL LINE; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; INTESTINE ABSORPTION; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; DIPYRIDAMOLE; FLAVONOIDS; HUMANS; INTESTINAL ABSORPTION; P-GLYCOPROTEIN; PROPIONATES; QUINOLINES; VERAPAMIL;

EID: 84893110603     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules19010686     Document Type: Article

References (33)

1. Wu, Y.T.; Lin, C.W.; Lin, L.C.; Chiu, A.W.; Chen, K.K.; Tsai, T.H. Analysis of biliary excretion of icariin in rats. J. Agric. Food Chem. 2010, 58, 9905-9911.
2. Meng, F.H.; Li, Y.B.; Xiong, Z.L.; Jiang, Z.M.; Li, F.M. Osteoblastic proliferative activity of Epimedium brevicornum Maxim. Phytomedicine 2005, 12, 189-193.
3. Wang, Y.K.; Huang, Z.Q. Protective effects of icariin on human umbilical vein endothelial cell injury induced by H2O2 in vitro. Pharmacol. Res. 2005, 52, 174-182.
4. An, D.N.; Victoria, P.; Stuart, M.; Denis, D.K. Estrogenic activity of a polyphenolic extract of the leaves of epimedium brevicornum. Fitoterapia 2005, 76, 35-40.
5. Zhang, H.F.; Yang, T.S.; Li, Z.Z.; Wang, Y. Simultaneous extraction of epimedin A, B, C and icariin from herba epimedii by ultrasonic technique. Ultrason. Sonochem. 2008, 15, 376-385.
6. Lin, C.C.; Ng, L.T.; Hsu, F.F.; Shieh, D.E.; Chiang, L.C. Cytotoxic effects of Coptis chinensis and Epimedium sagittatum extracts and their major constituents (berberine, coptisine and icariin) on hepatoma and leukaemia cell growth. Clin. Exp. Pharmacol. Physiol. 2004, 31, 65-69.
7. Liu, T.Z.; Chen, C.Y.; Yiin, S.J.; Chen, C.H.; Cheng, J.T.; Shih, M.K.; Wang, Y.S.; Chern, C.L. Molecular mechanism of cell cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through suppression of mitogen-Activated protein kinase activation and increased expression of CDK inhibitors p21(Cip1) and p27(Kip1). Food Chem. Toxicol. 2006, 44, 227-235.
8. Yap, S.P.; Shen, P.; Butler, M.S.; Gong, Y.; Loy, C.J.; Yong, E.L. New estrogenic prenylflavone from Epimedium brevicornum inhibits the growth of breast cancer cells. Planta Med. 2005, 71, 114-119.
9. Chen, Y.; Zhao, Y.H.; Jia, X.B.; Hu, M. Intestinal absorption mechanisms of prenylated flavonoids present in the heat-processed Epimedium. koreanum Nakai. (Yin Yanghuo). Pharm. Res. 2008, 25, 2190-2199.
10. Peterson, M.D.; Mooseker, M.S. Characterization of the enterocyte-like brush border cytoskeleton of the C2BBe clones of the human intestinal cell line, Caco-2. J. Cell Sci. 1992, 102, 581-600.
11. Li, C.R.; Zhang, L.; Zhou, L.B.; Wo, S.K.; Lin, G.; Zuo, Z. Comparison of intestinal absorption and disposition of structurally similar bioactive flavones in Radix Scutellariae. AAPS J. 2012, 14, 23?33.
12. Planas, J.M.; Alfaras, I.; Colom, H.M.; Juan, M.E. The bioavailability and distribution of transresveratrol are constrained by ABC transporters. J. Arch. Biochem. Biophys. 2012, 527, 67?73.
13. Fricker, G.; Miller, D.S. Relevance of multidrug resistance proteins for intestinal drug absorption in vitro and in vivo. J. Pharmacol. Toxicol. 2002, 90, 5?13.
14. Juan, M.E.; González-Pons, E.; Planas, J.M. Multidrug resistance proteins restrain the intestinal absorption of trans-resveratrol in rats. J. Nutr. 2010, 140, 489?495.
15. Hellwig, M.; Geissler, S.; Matthes, R.; Peto, A.; Silow, C.; Brandsch, M.; Henle, T. Transport of free and peptide-bound glycated amino acids: Synthesis, transepithelial flux at Caco-2 cell monolayers, and interaction with apical membrane transport proteins. ChemBioChem 2011, 12, 1270?1279.
16. Van de Wetering, K.; Burkon, A.; Feddema, W.; Bot, A.; de Jonge, H.; Somoza, V.; Borst, P. Intestinal breast cancer resistance protein (BCRP)/Bcrp1 and multidrug resistance protein 3 (MRP3)/Mrp3 are involved in the pharmacokinetics of resveratrol. Mol. Pharmacol. 2009, 75, 876?885.
17. Mease, K.; Sane, R.; Podila, L.; Taub, M.E. Differential selectivity of efflux transporter inhibitors in Caco-2 and MDCK-MDR1 Monolayers: A strategy to assess the interaction of a new chemical entity with P-gp, BCRP, and MRP2. J. Pharm. Sci. 2012, 101, 1888?1897.
18. Dahan, A.; Sabit, H.; Amidon, G.L. Multiple efflux pumps are involved in the transepithelial transport of colchicine: Combined effect of p-glycoprotein and multidrug resistance-Associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine. J. Drug Metab. Dispos. 2009, 37, 2028?2036.
19. Brand, W.; van der Wel, P.A.; Rein, M.J.; Barron, D.; Williamson, G.; van Bladeren, P.J.; Rietiens, M. Metabolism and transport of the citrus flavonoid hesperetin in Caco-2 cell monolayers. Drug Metab. Dispos. 2008, 36, 1794?1802.
20. Jeong, E.J.; Liu, Y.; Lin, H.; Hu, M. In situ single-pass perfused rat intestinal model for absorption and metabolism. In Methods in Pharmacology and Toxicology -Optimization in Drug Discovery: In Vitro Methods; Yan, Z., Caldwell, G.W., eds.; Human Press: Totowa, NJ, USA, 2004; pp. 65-76.
21. Liang, E.; Proudfoot, J.; Yazdanian, M. Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolyers. Pharm. Res. 2000, 17, 1168?1174.
22. Xia, C.Q.; Liu, N.; Yang, D.; Miwa, G.; Gan, L.S. Expression, localization, and functional characteristics of breast cancer resistance protein in Caco-2 cells. Drug Metab. Dispos. 2005, 33, 637?643.
23. Kobayashi, S.; Shinohara, M.; Nagai, T.; Konishi, Y. Transport mechanisms of soy isoflavones and their microbial metabolites dihydrogenistein and dihydrodaidzein across monolayers and membranes. Pharm. Anal. Acta 2013, 77, 2210?2217.
24. Schutte, M.E.; Freidig, A.P.; van de Sandt, J.J.; Alink, G.M.; Rietjens, I.M.; Groten, J.P. An in vitro and in silico study on the flavonoid-mediated modulation of the transport of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through Caco-2 monolayers. Toxicol. Appl. Pharmacol. 2006, 217, 204?215.
25. Xue, C.F.; Guo, J.M.; Qian, D.W.; Duan, J.A.; Shu, Y. Absorption of flavonoids from Abelmoschus manihot extract by in situ intestinal perfusion. Yao Xue Xue Bao 2011, 46, 454?459.
26. Wolfgang, L.; Heidrun, P. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRX 2005, 2, 86?98.
27. Akao, T.; Hanada, M.; Sakashita, Y.; Sato, K.; Morita, M.; Imanaka, T. Efflux of baicalin, a flavone glucuronide of Scutellariae Radix, on Caco-2 cells through multidrug resistanceassociated protein 2. J. Pharm. Pharmacol. 2007, 59, 87?93.
28. Lin, J.B.; Dou, J.; Xu, J.L.; Haji, A.A. Chemical composition, antimicrobial and antitumor activities of the essential oils and crude extracts of Euphorbia macrorrhiza. Molecules 2012, 17, 5030-5039.
29. Hu, M.; Chen, J.; Zhu, Y.; Dantzig, A.H.; Stratford, R.E., Jr.; Kuhfeld, M.T. Mechanism and kinetics of transcellular transport of a new beta -lactam antibiotic loracarbef across an intestinal epithelial membrane model system (Caco-2). Pharm. Res. 1994, 11, 1405-1413.
30. Lv, L.Z.; Tong, C.Q.; Lv, Q.; Tang, X.J.; Li, L.M.; Fang, Q.X.; Yu, J.; Han, M.; Gao, J.Q. Enhanced absorption of hydroxysafflor yellow A using a self-double-emulsifying drug delivery system: In vitro and in vivo studies. Int. J. Nanomed. 2012, 7, 4099-4107.
31. Guan, M.; Zhu, Q.L.; Liu, Y.; Bei, Y.Y.; Gu, Z.L.; Zhang, X.N.; Zhang, Q. Uptake and transport of a novel anticancer drug-delivery system: Lactosyl-norcantharidin-Associated N-trimethyl chitosan nanoparticles across intestinal Caco-2 cell monolayers. Int. J. Nanomed. 2012, 7, 1921-1930.
32. Karamustafa, F. Transport of Alendronate Through Human Intestinal Cell Line Caco-2. In Proceedings of the 33rd Annual Meeting & Exposition of the Controlled Release Society, Vienna, Austria, 22-26 June 2006.
33. Lev, B.; Valery, A. Effects of polyether-modified poly(acrylic acid) microgels on doxorubicin transport in human intestinal epithelial Caco-2 cell. J. Control. Release 2003, 88, 11-22.